Your browser doesn't support javascript.
loading
Involvement of HSP90 in ischemic postconditioning-induced cardioprotection by inhibition of the complement system, JNK and inflammation
Wang, Dong-Xiao; Huang, Zheng; Li, Qing-Jie; Zhong, Guo-Qiang; He, Yan; Huang, Wei-Qiang; Cao, Xiao-Li; Tu, Rong-Hui; Meng, Jian-Jun.
  • Wang, Dong-Xiao; Guang Xi Medical University. First Affiliated Hospital. Department of Cardiology. CN
  • Huang, Zheng; Guang Xi Medical University. First Affiliated Hospital. Department of Cardiology. CN
  • Li, Qing-Jie; Guang Xi Medical University. Second Affiliated Hospital. Department of Cardiology. CN
  • Zhong, Guo-Qiang; Guang Xi Medical University. First Affiliated Hospital. Department of Cardiology. CN
  • He, Yan; Guang Xi Medical University. First Affiliated Hospital. Department of Geriatric Cardiology. CN
  • Huang, Wei-Qiang; Guang Xi Key Laboratory of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention. CN
  • Cao, Xiao-Li; Guang Xi Clinical Research Center for Cardiocerebrovascular Diseases. CN
  • Tu, Rong-Hui; Guang Xi Medical University. First Affiliated Hospital. Department of Geriatric Cardiology. CN
  • Meng, Jian-Jun; Guang Xi Medical University. First Affiliated Hospital. Geriatric Health Care Center. CN
Acta cir. bras ; 35(1): e202000105, 2020. tab, graf
Article Dans Anglais | LILACS | ID: biblio-1088523
ABSTRACT
Abstract Purpose To investigate whether heat shock protein 90 (HSP90) is involved in complement regulation in ischemic postconditioning (IPC). Methods The left coronary artery of rats underwent 30 min of occlusion, followed by 120 min of reperfusion and treatment with IPC via 3 cycles of 30s reperfusion and 30s occlusion. The rats were injected intraperitoneally with 1 mg/kg HSP90 inhibitor geldanamycin (GA) after anesthesia. Eighty rats were randomly divided into four groups sham, ischemia-reperfusion (I/R), IPC and IPC + GA. Myocardial infarct size, apoptosis index and the expression of HSP90, C3, C5a, tumor necrosis factor (TNF)-alpha, interleukin (IL)-1β and c-Jun N-terminal kinase (JNK) were assessed. Results Compared with the I/R injury, the IPC treatment significantly reduced infarct size, release of troponin T, creatine kinase-MB, and lactate dehydrogenase, and cardiomyocyte apoptosis. These beneficial effects were accompanied by a decrease in TNF-α, IL-1β, C3, C5a and JNK expression levels. However, all these effects were abrogated by administration of the HSP90 inhibitor GA. Conclusion HSP90 exerts a profound effect on IPC cardioprotection, and may be linked to the inhibition of the complement system and JNK, ultimately attenuating I/R-induced myocardial injury and apoptosis.
Sujets)


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Protéines du système du complément / Lésion de reperfusion myocardique / Benzoquinones / Protéines du choc thermique HSP90 / Lactames macrocycliques / JNK Mitogen-Activated Protein Kinases / Infarctus du myocarde Limites du sujet: Animaux langue: Anglais Texte intégral: Acta cir. bras Thème du journal: Chirurgie générale / Procedimentos Cir£rgicos Operat¢rios Année: 2020 Type: Article Pays d'affiliation: Chine Institution/Pays d'affiliation: Guang Xi Clinical Research Center for Cardiocerebrovascular Diseases/CN / Guang Xi Key Laboratory of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention/CN / Guang Xi Medical University/CN

Documents relatifs à ce sujet

MEDLINE

...
LILACS

LIS


Texte intégral: Disponible Indice: LILAS (Amériques) Sujet Principal: Protéines du système du complément / Lésion de reperfusion myocardique / Benzoquinones / Protéines du choc thermique HSP90 / Lactames macrocycliques / JNK Mitogen-Activated Protein Kinases / Infarctus du myocarde Limites du sujet: Animaux langue: Anglais Texte intégral: Acta cir. bras Thème du journal: Chirurgie générale / Procedimentos Cir£rgicos Operat¢rios Année: 2020 Type: Article Pays d'affiliation: Chine Institution/Pays d'affiliation: Guang Xi Clinical Research Center for Cardiocerebrovascular Diseases/CN / Guang Xi Key Laboratory of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention/CN / Guang Xi Medical University/CN